GlassScriptPhysician profile
Matthew H Recht
NPI 1033114616
$73,005.85
in general payments reported to CMS, 2019-2025
30 companies · $15K in 2025
The $15K reported for 2025 was more than what 93% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,118 · 2020: $12K · 2021: $15K · 2022: $12K · 2023: $4,137 · 2024: $13K · 2025: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Food and Beverage: $6,179 · Travel and Lodging: $4,546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,066.45 |
| Food and Beverage | $6,178.65 |
| Travel and Lodging | $4,545.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bolton Medical INC | $34,054.04 | 2020-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Cardiva Medical, INC. | $18,414.12 | 2021-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 5f Vcs |
| W. L. Gore & Associates, INC. | $7,563.19 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Gore Excluder Iliac Branch Endoprosthesis |
| Bard Peripheral Vascular, INC. | $2,599.26 | 2019-2025 | Venovo |
| Becton, Dickinson and Company | $2,450.00 | 2020 | |
| Penumbra, INC. | $1,880.55 | 2019-2025 | Indigo System, Penumbra System |
| Abbott Laboratories | $1,684.16 | 2019-2024 | Jeti, Perclose Proglide |
| Philips North America LLC | $466.67 | 2019-2023 | |
| Silk Road Medical, INC. | $465.00 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Medtronic, INC. | $396.50 | 2021-2025 | Heli-Fx Endoanchor System, Endurant Iis |
| Angiodynamics, INC. | $388.80 | 2019-2024 | Alphavac, Angiovac |
| Shockwave Medical, INC | $344.54 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cook Medical LLC | $327.04 | 2019-2022 | |
| Shape Memory Medical INC. | $296.67 | 2024-2025 | Impede Embolization Plug |
| Cardiovascular Systems INC. | $291.84 | 2019-2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $291.63 | 2019-2024 | Stravix |
| Surmodics, INC. | $193.96 | 2021 | |
| Boston Scientific Corporation | $181.97 | 2019 | |
| Inari Medical, INC. | $145.69 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Reflow Medical INC | $139.03 | 2024-2025 | |
| Janssen Scientific Affairs, LLC | $114.65 | 2022 | |
| Biocompatibles, INC. | $71.96 | 2019 | |
| Avinger INC. | $67.98 | 2019 | |
| Contego Medical, INC | $61.83 | 2023 | |
| Pfizer INC. | $33.77 | 2022-2024 | |
| Endologix LLC | $27.16 | 2022 | |
| Lemaitre Vascular, INC. | $25.25 | 2025 | Artegraft Vascular Graft |
| Medtronic Vascular, INC. | $14.62 | 2020 | |
| Janssen Pharmaceuticals, INC | $13.97 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Recht listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.